Baseline metabolic tumour volume is an independent prognostic factor in Hodgkin lymphoma-Reference-Cited by-同舟云学术

Baseline metabolic tumour volume is an independent prognostic factor in Hodgkin lymphoma

Published:2014-05-09 Issue:9 Volume:41 Page:1735-1743
ISSN:1619-7070
Container-title:European Journal of Nuclear Medicine and Molecular Imaging
language:en
Short-container-title:Eur J Nucl Med Mol Imaging

Author:

Kanoun Salim,Rossi Cédric,Berriolo-Riedinger Alina,Dygai-Cochet Inna,Cochet Alexandre,Humbert Olivier,Toubeau Michel,Ferrant Emmanuelle,Brunotte François,Casasnovas René-Olivier

Publisher

Springer Science and Business Media LLC

Subject

Radiology Nuclear Medicine and imaging,General Medicine,Radiology Nuclear Medicine and imaging,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00259-014-2783-x.pdf

Reference40 articles.

1. Hasenclever D, Diehl V. A prognostic score for advanced Hodgkin’s disease. International Prognostic Factors Project on Advanced Hodgkin’s Disease. N Engl J Med. 1998;339:1506–14.

2. Specht L, Nordentoft AM, Cold S, Clausen NT, Nissen NI. Tumor burden as the most important prognostic factor in early stage Hodgkin’s disease. Relations to other prognostic factors and implications for choice of treatment. Cancer. 1988;61:1719–27.

3. Willett CG, Linggood RM, Leong JC, Miketic LM, Stracher MA, Skates SJ, et al. Stage IA to IIB mediastinal Hodgkin’s disease: three-dimensional volumetric assessment of response to treatment. J Clin Oncol. 1988;6:819–24.

4. Gobbi PG, Ghirardelli ML, Solcia M, Di Giulio G, Merli F, Tavecchia L, et al. Image-aided estimate of tumor burden in Hodgkin’s disease: evidence of its primary prognostic importance. J Clin Oncol. 2001;19:1388–94.

5. Gobbi PG, Broglia C, Di Giulio G, Mantelli M, Anselmo P, Merli F, et al. The clinical value of tumor burden at diagnosis in Hodgkin lymphoma. Cancer. 2004;101:1824–34.

Cited by 148 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hodgkin Lymphoma: Next Questions;Clinical Lymphoma Myeloma and Leukemia;2024-09

2. Quantitative Assessment and Predictive Modelling for Treatment Response in Hodgkin's Lymphoma Using 18FDG PET/CT: A Novel Approach;2024-08-17

3. Prognostic value of the combination of volume, massiveness and fragmentation parameters measured on baseline FDG pet in high-burden follicular lymphoma;Scientific Reports;2024-04-05

4. Prognostic Value of Baseline Tumor Burden and Tumor Dissemination Extracted From 18F-FDG PET/CT in a Cohort of Adult Patients With Early or Advanced Hodgkin Lymphoma;Clinical Nuclear Medicine;2023-11-24

5. A different perspective on PET/CT before treatment in patients with Hodgkin lymphoma: importance of volumetric and dissemination parameters;Annals of Hematology;2023-11-15